Has Vincent Rampersaud, MD received payments from drug or device companies?

Yes. Drug and device makers reported $24,224 in general payments to Vincent Rampersaud, MD across 463 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vincent Rampersaud, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vincent Rampersaud, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vincent Rampersaud, MD

Interventional Pain Medicine · Flint, MINPI 1144348152

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Nalu Medical, Inc. at 47.0% of the total. 2025 is the largest year on record at $13,417, more than ten times the $532 reported in 2019.

$24,224in general payments, 2019–2025

Across 463 payments — averaging $52.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nalu Medical, Inc.$11K
Nevro Corp.$2K
Boston Scientific$2K
Medtronic$2K
Saluda Medical Americas, Inc.$2K
AbbVie$1K
plus $5K from 22 others

$131,459in research payments, 2019–2025

Across 13 payments — averaging $10,112 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Indivior Inc.$131K

What the payments were for

Consulting fees$8,10033%
Travel & lodging$4,03317%
Food & beverage$12,09250%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nalu Medical, Inc.	37	$11,385
Nevro Corp.	28	$1,852
Boston Scientific	26	$1,804
Medtronic(2 entities)	28	$1,744
Saluda Medical Americas, Inc.	4	$1,525
AbbVie(2 entities)	122	$1,232
Globus Medical	12	$929
Amgen	92	$780
Forte Bio-pharma LLC	61	$665
Abbott	17	$505
Stryker	4	$303
Brixton Biosciences, Inc.	3	$303
Averitas Pharma Inc.	3	$208
Painteq LLC	3	$186
Curonix LLC	2	$155
Spinal Simplicity, LLC	2	$150
MML US, Inc.	1	$135
Si-bone, Inc.	4	$117
Biohaven Pharmaceutical Holding Company Ltd.	2	$44
Pfizer	2	$37
Biodelivery Sciences International, Inc.	2	$31
Tersera Therapeutics LLC	2	$30
Scilex Pharmaceuticals Inc.	1	$25
Relievant Medsystems, Inc.	1	$22
Merz North America, Inc.	1	$19
Bioventus LLC	1	$16
Hydrocision, Inc.	1	$12
GRT US Holding, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Nalu Neurostimulation System$10,808
Evoke$1,500
Senza$1,356
SYNCHROMEDII$837
GENERAL PAIN MANAGEMENT$720
Prolate$420
Vyrsa V1$245
UBRELVY$236
PROCLAIM$236
SPINEJACK$209
Neural Ice$158
HA MINUTEMAN G3-R$143
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$142
ReActiv8$135
PAINTEQ$133
Intracept RF Probe$127
Qutenza$121
PENNSAID$118
INTELLIS ADAPTIVESTIM$116
Senza Spinal Cord Stimulation System$115

How this compares

$24,224 in reported general payments places this provider in the 85th percentile of 88 interventional pain medicine providers in Michigan.

See all interventional pain medicine providers in Michigan →

Medicare billing

Part B allowed, 2024

$112,703

Medicare patients

255

Services billed

1,558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	98	$16,304
Buprenorphine	84	$14,500
BelbucaBuprenorphine Hcl	15	$11,028
MovantikNaloxegol Oxalate	11	$4,327
Diclofenac Sodium	127	$3,929
Methocarbamol	26	$3,398
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	207	$2,642
Gabapentin	217	$2,224
Acetaminophen-CodeineAcetaminophen With Codeine	60	$952
Pregabalin	69	$864
Morphine Sulfate ErMorphine Sulfate	57	$833
Tizanidine Hcl	83	$738
Celecoxib	21	$707
Cyclobenzaprine Hcl	48	$241
Morphine Sulfate	20	$236

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Flint

Evan PeskinFlint$72K
Siva SripadaFlint$10K
Ryan PollinaSaint Clair Shores$144K
Ariel MajjhooMonroe$124K
Chad BrummettAnn Arbor$109K
Anand ThakurClinton Township$102K
Richard FerroLansing$31K
John ChatasAnn Arbor$29K
Bryant IttiaraAllen Park$28K
Fadi DellyWyandotte$25K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →